Chica Mori - Concepedia

Author

Chica Mori

Harvard University

Also Known As

C Mori, C. MORI, Chica Mori

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Harvard University Brigham and Women's Hospital New York State Office for People With Developmental Disabilities Millennium Engineering and Integration (United States)

About

Chica Mori is an author at Harvard University specializing in medicine, immunology, and neuroimmunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	988
2	Immunology	5	5	884
3	Health Sciences	1	1	312
4	Social Sciences	1	1	263
5	Allergy	1	1	50

Chica Mori

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Nasal administration of amyloid-beta peptide decreases cerebral amyloid burden in a mouse model of Alzheimer's disease. Howard L. Weiner, Cynthia A. Lemere, Ruth Maron, PubMed Cerebral Amyloid BurdenNasal AdministrationImmunologyNeurochemical BiomarkersProgressive Cerebral Deposition	2000	312
Nasal administration of amyloid-? peptide decreases cerebral amyloid burden in a mouse model of Alzheimer's disease Howard L. Weiner, Cynthia A. Lemere, Ruth Maron, Annals of Neurology Cerebral Amyloid BurdenSystemic DiseasesNasal AdministrationImmunologyImmune Regulation	2000	263
Intraneuronal Aβ42 accumulation in Down syndrome brain Chica Mori, E. T. C. Spooner, Krystyna E. Wisniewski, Amyloid	2002	253
Temporal Accrual of Complement Proteins in Amyloid Plaques in Down's Syndrome with Alzheimer's Disease Sarah Stoltzner, Trelawney J. Grenfell, Chica Mori, American Journal Of Pathology Down SyndromeComplement SystemAlzheimer's DiseaseAmyloid PlaquesMedicine	2000	189
Nasal Aβ Treatment Induces Anti‐Aβ Antibody Production and Decreases Cerebral Amyloid Burden in PD‐APP Mice Cynthia A. Lemere, Ruth Maron, E. T. C. Spooner, Annals of the New York Academy of Sciences Neurodegenerative DiseasesPd‐app MiceMedicineDegenerative PathologyNeuroscience	2000	104
Intranasal immunotherapy for the treatment of Alzheimer’s disease: Escherichia coli LT and LT(R192G) as mucosal adjuvants Cynthia A. Lemere, E. T. C. Spooner, Jodi F. Leverone, Neurobiology of Aging Mucosal VaccinationAlzheimer's DiseaseMicrobial PathogensMedicineAntibiotic Adjuvant	2002	70
The generation and characterization of potentially therapeutic Aβ antibodies in mice: differences according to strain and immunization protocol E. T. C. Spooner, Roanak V Desai, Chica Mori, Vaccine AllergyImmunologyImmune RegulationImmunodominanceTherapeutic Aβ Antibodies	2002	50

Page 1